The risk profile of glaucoma filtration surgery

Current Opinion in Ophthalmology

Volumn 10, Issue 2, 1999, Pages 112-116

  Borisuth, Navaneet S C ^a   Phillips, Bryan ^a   Krupin, Theodore ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUOROURACIL; MITOMYCIN C;

ANTIBIOTIC THERAPY; ARTICLE; CATARACT; ENDOPHTHALMITIS; FILTERING OPERATION; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; NEGRO; NEOVASCULAR GLAUCOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT FAILURE; UVEITIS;

GLAUCOMA; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRABECULECTOMY; TREATMENT FAILURE;

EID: 0032774957     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199904000-00006     Document Type: Article

References (26)

1. 1 Cairns JE: Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 1968, 66:673-679.
2. 2 Coleman AL, Yu F, Greenland S: Factors associated with elevated complication rates after partial-thickness or full-thickness glaucoma surgical procedures in the United States during 1994. Ophthalmology 1997, 105:1165-1169. Using the Medicare database of a total of 27,886 cases of partial-and full-thickness filtration surgeries performed between 1984 and 1990, the authors identified full-thickness procedures, concomitant vitrectomy, and inpatient hospitalization as increasing the risk of complications after surgery.
3. 3 Shin DH, Ren J, Juzych MS, Hughes BA, Kim C, Song MS, et al.: Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol 1998, 125:346-352. Adjunctive MMC significantly improved the filtration outcome of the primary glaucoma triple procedure in patients with one of three prognostic factors for filtration failure: African-American race, a preoperative IOP of 20 mm Hg or more on maximum tolerated medications, and being on two or more medications preoperatively.
4. 4 Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr: Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996, 114:943-949.
5. 5 Aaberg TMJ, Flynn HW, Schiffman J, Newton J: Nosocomial acute-onset postoperative endophthalmitis survey. Ophthalmology 1998, 105:1004-1010.
6. 6 Quigley HA: Reappraising the risks and benefits of aggressive glaucoma therapy. Ophthalmology 1997, 104:1985-1986.
7. 7 Zacharia PT, Deppermann SR, Schuman JS: Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 1993, 116:314-326.
8. 8 Siegfried CJ, Rosenberg LF, Krupin T, Jampol LM: Hypotony after glaucoma filtration surgery: mechanisms and incidence of glaucoma. J Glaucoma 1995,4:63-69.
9. 9 Shields MB, Scroggs MW, Sloop SM, Simmons RB: Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 1993, 11 6:673-683.
10. 10 Singh K, Byrd S, Egbert PR, Budenz D: Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black West African population. J Glaucoma 1998, 7:82-85.
11. 11 Sihota R, Sharma T, Agarwal HC: Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand 1998, 76:80-82.
12. 12 Greenfield DS, Liebmann JM, Jee J, Ritch R: Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998, 116:443-447. Prospective study of 525 patients undergoing glaucoma filtering surgery with or without adjunctive antifibrotics. The risk of late-onset focal bleb-leaks increases following trabeculectomy with MMC. Late leakage is infrequent after combined cataract and glaucoma surgery.
13. 13 Chen TC, Wilensky JT, Viana MAG: Long-term follow-up of initially successful trabeculectomy. Ophthalmology 1997, 104:1120-1125. Long-term outcome study of patients undergoing primary trabeculectomy without adjunctive antifibrotic therapy. In eyes with successful surgery at 1 year, the probabilities for successful control of IOP were 82%, 67%, and 67% at 5, 10, and 15 years, respectively.
14. 14 The AGIS Investigators: The Advanced Glaucoma Intervention Study (AGIS): 4: comparison of treatment outcomes within race: seven-year results. Ophthalmology 1998, 105:1146-1164. This National Eye Institute-sponsored, multicenter, randomized, controlled trial, initiated in 1988, compared the visual outcomes for two sequences of surgical glaucoma therapy: ATT versus TAT. Through 7 years of follow-up, the results suggest that, in order to minimize vision loss in patients with advanced glaucoma, the first surgical intervention should be ALT in blacks and trabeculectomy in whites.
15. 15 Chen CW: Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia-Pacific Acad Ophthalmol 1983, 9:172-177.
16. 16 Parrish RK, Folberg R: Wound healing in glaucoma filtration surgery. In The Glaucomas, edn 2. Edited by Ritch R, Shields MB, Krupin T. St. Louis: Mosby Year-Book; 1996:1633-1651.
17. 17 Nuijts RMMA, Vernimmen RCJ, Webers CA: Mitomycin C primary trabeculectomy in primary glaucoma of white patients. J Glaucoma 1997, 6:293-297.
18. 18 Scott IU, Greenfield DS, Schiffman J, Nicolela MT, Rueda JC, Tsai JC, Palmberg PF: Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 1998, 116:286-291. One-and 2-year success rates for patients undergoing primary trabeculectomy with MMC were 86% and 78%, respectively. Endophthalmitis and hypotony occurred in 2.2% and 4.5%, respectively, of the cohort group.
19. 19 Perkins TW, Gangnon R, Ladd W, Kaufman PL, Heatley GA: Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma 1998, 7:230-236.
20. 20 Stone RT, Herndon LW, Allingham RR, Shields MB: Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure. J Glaucoma 1998, 7:39-44.
21. 21 The 5-FU Study Group: Five year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996, 121:349-366.
22. 22 Anand N, Sahni K, Menage MJ: Modification of trabeculectomy with single-dose intraoperative 5-fluorouracil application. Acta Ophthalmol Scand 1998, 76:83-89.
23. 23 Raina UK, Tuli D: Trabeculectomy with releasable sutures: a prospective, randomized pilot study. Arch Ophthalmol 1998, 116:1288-1293.
24. 24 Lemon LC, Shin DH, Kim C, Bendel RE, Hughes BA, Juzych MS: Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. Am J Ophthalmol 1998, 125:340-345.
25. 25 Park HJ, Kwon YH, Weitzman M, Caprioli J: Temporal corneal phacoemulsification in patients with filtered glaucoma. Arch Ophthalmol 1997, 115:1375-1380.
26. 26 Wyse T, Meyer M, Ruderman JM, Krupin T, Talluto D, Hernandez R, Rosenberg LF: Combined trabeculectomy and phacoemulsification: a one-site vs a two-site approach. Am J Ophthalmol 1998, 125:334-339. Patients undergoing one-site combined surgery ultimately require significantly more medication for IOP control than patients undergoing separate-site phacoemulsification and trabeculectomy combined surgery.